(1)
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS. Mediterr J Hematol Infect Dis 2018, 10 (1), e2018028. https://doi.org/10.4084/mjhid.2018.028.